CRVO

CERVOMED INC

CRVO·15713L109·US·Common Stock·Healthcare - Biotechnology-Activist

CRVO (CERVOMED INC) is held by 24 institutional investors as of Q1 2026. Largest holders: MORGAN STANLEY ($2.9M), VANGUARD CAPITAL MANAGEMENT LLC ($1.2M), MILLENNIUM MANAGEMENT LLC ($823,098). Net institutional sentiment: Mixed.

24
Holders
Avg rating(8 Elite)
$6.6M
Total Value
54% (33)
Fund Consensus
14 buying - 12 selling
CRVOSmart Money Verdict
View all
Held by 24 funds
8 elite
Who's Trading
ActivistMorgan StanleyMorgan Stanley0.1%Jul 8, 2026
ActivistCICVI Investments, Inc.5.5%Jun 26, 2026
ActivistBJBOGER JOSHUA S20.0%Jun 15, 2026
ActivistMorgan StanleyMorgan Stanley8.0%May 11, 2026
ActivistAIAWM Investment Company, Inc.4.2%Apr 7, 2026
InsiderWMWinton MatthewBuy $12KNov 18, 2025
InsiderERELDER WILLIAM ROBERTBuy $21KNov 18, 2025
InsiderAJALAM JOHN JBuy $91KNov 17, 2025
InsiderGSGregoire SylvieBuy $91KNov 17, 2025
InsiderWMWinton MatthewBuy $30KNov 17, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
739,892(+55.9%)$2.9M0.0%-45.33%
37
New
316,202$1.2M0.0%-10.97%
39
Increased
208,908(+246.6%)$823,0980.0%-22.37%
40
Increased
74,371(+12.9%)$293,0920.0%-72.59%
18
New
63,904$251,7820.0%-10.97%
32
Increased
51,660(+5.1%)$203,5400.0%+20.23%
16
Increased
38,487(+273.4%)$151,6390.0%-29.63%
36
New
36,151$142,4350.0%-10.97%
34
Decreased
30,044(-2.0%)$118,3730.0%-72.15%
0
Unchanged
27,337$107,7080.0%-55.82%
0
Unchanged
20,527$80,8760.0%-75.36%
0
Increased
18,246(+64.7%)$71,8890.0%-44.39%
21
Unchanged
16,090$63,3950.0%-62.61%
0
Increased
11,265(+0.2%)$44,3840.0%-62.30%
14
Decreased
11,040(-2.5%)$43,4980.0%-59.21%
0
Increased
5,239(+402.3%)$20,6410.0%-7.29%
21
New
2,597$10,2320.0%-10.97%
26
New
1,700$6,6980.0%-10.97%
24
New
283$1,0000.0%-10.97%
17
Unchanged
251$9890.0%-56.51%
0

Showing 1-20 of 33

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used